FDA
approval
· 2023-11-01
FDA Approved: VENLAFAXINE — Supplemental Application (Zydus Lifesciences Limited)
Summary
FDA granted supplemental approval for venlafaxine from Zydus Lifesciences Limited, signaling an approved modification to an existing generic drug application.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VENLAFAXINE (VENLAFAXINE)